Vitamin D3 supplementation is linked to reduced tumour growth in the colon, but colorectal tumours may also overexpress the vitamin‐D‐degrading enzyme CYP24A1, potentially undermining the benefits of vitamin D intake. Here, CYP24A1 is linked to neoplasm.